RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Xlife Sciences Stock

Xlife Sciences ROCE 2024

Xlife Sciences ROCE

-0.08

Ticker

XLS.SW

ISIN

CH0461929603

WKN

A2PK6Z

In 2024, Xlife Sciences's return on capital employed (ROCE) was -0.08, a -15.2% increase from the -0.09 ROCE in the previous year.

Xlife Sciences Aktienanalyse

What does Xlife Sciences do?

Xlife Sciences AG is a company active in the field of biotechnology. The company was founded in 2017 and is based in Switzerland. The main activity of Xlife Sciences AG is the identification and development of biotechnology products, particularly in the field of health sciences. The business model of Xlife Sciences AG is based on collaborations with leading scientists and research groups worldwide. The company identifies promising research areas and takes on the financing and development of projects until they are marketable. Xlife Sciences AG works closely with academic environments, universities, research institutes, venture capital firms, and other partners. Xlife Sciences AG specializes in three main divisions: Human Health, Agrifood, and Industrial Biotechnology. Under the Human Health division, the company develops drugs and therapies for various diseases and health problems. These include cancer, diabetes, cardiovascular diseases, infectious diseases, and autoimmune diseases. The Agrifood division of Xlife Sciences AG works on innovative solutions for agriculture and food production. This includes the development of plants that are resistant to pests and drought, as well as the development of foods with functional properties such as increased nutritional value or improved durability. The Industrial Biotechnology division of Xlife Sciences AG focuses on the development of biotechnological products for industrial use. This includes biofuels made from renewable raw materials and the production of biobased materials such as plastics and textiles. An example of a product developed by Xlife Sciences AG is a new drug against cancer. This drug was developed in collaboration with the University of Basel and has the potential to revolutionize cancer treatment. The effectiveness of the drug has already been proven in animal tests, and preparations for clinical trials are underway. Overall, Xlife Sciences AG aims to develop innovative technologies and products that improve people's lives while also being economically successful. The company relies on close cooperation with scientists, investors, and industry partners. Xlife Sciences AG has established itself as an important player in the biotechnology industry and continuously works to expand its range of products and services. Although the company is relatively young, it already has numerous promising projects in the pipeline and strives to develop innovative solutions for the challenges of our time in the future. Xlife Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Xlife Sciences's Return on Capital Employed (ROCE)

Xlife Sciences's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Xlife Sciences's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Xlife Sciences's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Xlife Sciences’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Xlife Sciences stock

What is the ROCE (Return on Capital Employed) of Xlife Sciences this year?

The ROCE of Xlife Sciences is -0.08 undefined this year.

How has the ROCE (Return on Capital Employed) of Xlife Sciences developed compared to the previous year?

The ROCE of Xlife Sciences has increased by -15.2% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Xlife Sciences?

A high Return on Capital Employed (ROCE) indicates that Xlife Sciences has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Xlife Sciences?

A low ROCE (Return on Capital Employed) can indicate that Xlife Sciences has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Xlife Sciences impact the company?

An increase in the ROCE of Xlife Sciences can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Xlife Sciences affect the company?

A decrease in ROCE of Xlife Sciences can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Xlife Sciences?

Some factors that can affect Xlife Sciences's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Xlife Sciences so important for investors?

The ROCE of Xlife Sciences is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Xlife Sciences take to improve the ROCE?

To improve the ROCE, Xlife Sciences can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Xlife Sciences pay?

Over the past 12 months, Xlife Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Xlife Sciences is expected to pay a dividend of 0 CHF.

What is the dividend yield of Xlife Sciences?

The current dividend yield of Xlife Sciences is .

When does Xlife Sciences pay dividends?

Xlife Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Xlife Sciences?

Xlife Sciences paid dividends every year for the past 0 years.

What is the dividend of Xlife Sciences?

For the upcoming 12 months, dividends amounting to 0 CHF are expected. This corresponds to a dividend yield of 0 %.

In which sector is Xlife Sciences located?

Xlife Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Xlife Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Xlife Sciences from 11/16/2024 amounting to 0 CHF, you needed to have the stock in your portfolio before the ex-date on 11/16/2024.

When did Xlife Sciences pay the last dividend?

The last dividend was paid out on 11/16/2024.

What was the dividend of Xlife Sciences in the year 2023?

In the year 2023, Xlife Sciences distributed 0 CHF as dividends.

In which currency does Xlife Sciences pay out the dividend?

The dividends of Xlife Sciences are distributed in CHF.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Xlife Sciences

Our stock analysis for Xlife Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Xlife Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.